| Code | 8743B | ||||||||||
| MA number | 27/0167/16-S | ||||||||||
| Product Form: | tbl 7x1 mg (blis.PVC/Al/OPA/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Glenmark Pharmaceuticals s.r.o., Czechia | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 18 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.03.2016 |
| SPC: |
SPC_Rasagilin Glenmark 1 mg_08.2021.pdf
|
| PIL: |
PIL_Rasagilin Glenmark 1 mg_08.2021.pdf
|
| Safety feature | Yes |
| Data update: | 04.06.2020 |
